藥品查詢網(wǎng)的數(shù)據(jù)庫

1、藥物數(shù)據(jù)庫 本條目列出了一些常見的免費(fèi)藥物數(shù)據(jù)庫1美國FDA藥品數(shù)據(jù)庫：其網(wǎng)址為： HYPERLINK /scripts/cder/drugsatfda/.%e8%bf%99%e4%b8%aa%e6%95%b0%e6%8d%ae%e5%ba%93%e6%94%b6%e9%9b%86 /scripts/cder/drugsatfda/.這個數(shù)據(jù)庫收集 了美國上市的所有藥品申報資料.基本檢索方法可以使用新藥申請?zhí)?New drug applicationnumbei, NDA number),藥品活性成分名(Active Ingredient),藥品商品名(Drug Name)等幾種方法來檢索.高

2、級的檢索方法包含了上述基本檢索方法再加上時間參 數(shù).美國 FDA 藥品”橙色數(shù)據(jù)庫”(Electronic Orange Book)其網(wǎng)址為： HYPERLINK /cder/ob/default.htm.%e6%9c%ac%e6%95%b0%e6%8d%ae%e5%ba%93%e5%90%ab%e6%9c%89%e8%8d%af%e7%89%a9%e7%ad%89%e6%95%88%e6%80%a7%e8%af%84%e4%bb%b7%e4%bf%a1 /cder/ob/default.htm.本數(shù)據(jù)庫含有藥物等效性評價信 息，包括所有已批準(zhǔn)的藥品.其基本功能與FDA的上市藥品數(shù)據(jù)庫相似，可

3、以使用新藥申請 號(New drug application number, NDA number),藥品活性成分名(Active Ingredient), 藥品商品名(Drug Name),藥品申報機(jī)構(gòu)名(Applicant holder),藥品專利號等幾種方法來 檢索.在新藥申請?zhí)?，藥品活性成分名，藥品商品名，藥品申報機(jī)構(gòu)名的選項(xiàng)下，每中檢索方 法過包含了”處方藥”，非處方藥”(OTC),、停止上市藥”三種選擇項(xiàng).美國FDA上市藥品檢索系統(tǒng)(FDA Drug Index Database)這是中國藥物在線網(wǎng)()推出的FDA上市 藥品檢索平臺。 該數(shù)據(jù)庫包含F(xiàn)DA到目前為止已上市或曾經(jīng)上市的

4、全部藥品，幫助您快速獲知某藥品及相 關(guān)藥品在美國注冊、審批、專利等方面的重要信息。其網(wǎng)頁是： HYPERLINK /fda/db1_query.aspt /fda/db1_query.aspt 其特點(diǎn)是：1、支持模糊查詢和組合查詢，各條件間關(guān)系為邏輯與。例如在藥品商品名中輸入 Levofloxacin，即可查詢所有在美國上市的左氧氟沙星品種。2、有效成分和商品名不能少于3個字符，新藥申請?zhí)枮?位數(shù)字，格式為nnnnnn。 各檢索條件意義如下：*藥品通用名或有效成分：Drug generic nameActive ingredient。*藥品專利藥名或商品名：Brand name。*藥品注冊申請

5、號：Application number。* 藥物劑型或給藥途徑 D osage formroute of administration3、檢索結(jié)果包括：*商品名(英文名)、有效成分、劑型、規(guī)格、申請?zhí)枴a(chǎn)品號、市場狀態(tài)、TE代碼、批 準(zhǔn)日期、RLD代碼、藥品類別、申請機(jī)構(gòu)。*該藥品的美國專利號，專利失效日期、專利類別，并可直接一次性完整下載專利全文， 格式為PDF或TIF兩種。*市場獨(dú)占權(quán)保護(hù)情況，含獨(dú)占權(quán)類型及失效日期。*藥品注冊審批信息，含全部歷史審批數(shù)據(jù)，審批時間、審批類別、藥品說明書、綜述、 通知件等。PHRMA 臨床研 究中的藥物數(shù)據(jù)庫( HYPERLINK /index.p /i

6、ndex.p . pany=&status=3)Today, over 2,000 newmedicines are in development. Many of these potential new medicines will failin clinical trials, but some may represent tomorrows new treatments. Bringingeach new medicine to patients will require, on average, 10-15 years of testingand review. This databa

7、se includes medicines currently in clinical trials or atFDA for review. The information contained in this database was derived fromWolters Kluwer Healths Adis R&DInsight and is published with permissionunder license with Wolters Kluwer Health. PhRMA has not reviewed or verifiedthis information.5. 臨

8、床 研 發(fā) 中 的 新 藥 索 引 Infoknowmics( HYPERLINK /DrugIndex.html /DrugIndex.html)This index lists over 8900distinct drugs for the treatment and/or prevention of human diseases andmedical conditions. These products are part of our Infoknowmics Knowledgebasebecause they disclosed development activity in the

9、past 9 years. The indexincludes all types of drugs across all clinical indications. It includes drugsthat are currently in the discovery, preclinical or clinical stages ofdevelopment, drugs that have been approved and launched during this timeperiod, as well those that have been discontinued.For eac

10、h product, we listits various names including the proprietary name (also called the brand name ortrade name), which is usually followed the trademark (t。orregisteredtrademark(® )symbol. In addition,we provide the generic name(recommended orapproved by international and US nomenclature committees)

11、, as well as anyaliases which are typically laboratory code names, or new names assigned by alicensee or co-developer.The type of each product isalso given. This category includes traditional product types, such as drugs,antibiotics, vaccines, and hormones, as well as newer types of products such as

12、monoclonal antibodies and other types of recombinant proteins, celltherapeutics, gene therapy, DNA vaccines, antisense, and RNA interference-basedproducts.Each product is indexed to its Originator Company, for intellectual property purposes. Please note thatbecause out-licensing, co-development or o

13、ther types of partnerships may existfor each product, the Originator Company may not be the company currentlydeveloping the drug. The index was last updated on April 2, 2007 and can beviewed by Product Name or Product Type.6.藥物非活性成分?jǐn)?shù)據(jù)庫(Inactive Ingredient Searchfor Approved Drug Products)這是中國藥物在線網(wǎng)()

14、推出的美國FDA批準(zhǔn)藥物非活 性成分?jǐn)?shù)據(jù)庫.1、本數(shù)據(jù)庫為FDA批準(zhǔn)藥物所使用的非活性成分?jǐn)?shù)據(jù)庫，即FDA上市產(chǎn)品 中包含的輔料信息數(shù)據(jù)。2、檢索條件支持模糊查詢，各輸入條件間的檢索關(guān)系為邏輯與(即 AND關(guān)系)。3、檢索結(jié)果包括：非活性成分名稱、給藥途徑或劑型、CAS登記號、美國藥 典/FDA物質(zhì)登記系統(tǒng)唯一標(biāo)識碼、處方中輔料使用量。4、利用本數(shù)據(jù)庫可以為藥物研究開 發(fā)者提供輔料的安全用量的事實(shí)性數(shù)據(jù)。檢索方法包括：*非活性成分名稱(Inactive Ingredient)；*給藥途徑或劑型(Route; Dosage Form)；*CAS 登記號(CAS Number)；* 唯一標(biāo)識碼(U

15、nique Ingredient Identifier)加拿大藥物銀行 HYPERLINK http:/lims.drugbank.ca http:/lims.drugbank.ca其網(wǎng)址為： HYPERLINK http:/lims.drugbank.ca/.%e8%af%a5%e6%95%b0%e6%8d%ae%e5%ba%93%e5%90%ab%e6%9c%89%e8%8d%af%e5%93%81%e7%9a%84%e5%8c%96%e5%ad%a6,%e7%94%9f%e7%89%a9%e8%b5%84%e6%96%99%ef%bc%8c%e5%8c%85%e6%8b%ac%e8%8d

16、%af%e7%89%a9%e4%bd%9c http:/lims.drugbank.ca/.該數(shù)據(jù)庫含有藥品的化學(xué),生物資料，包括藥物作 用機(jī)制，藥品作用受體目標(biāo).共有4300多個藥物.其中FDA批準(zhǔn)的小分子藥物有1200多 個，生物藥物有113個.營養(yǎng)輔助藥物62個，正在臨床試驗(yàn)的藥物3000多個.美國處方藥索引網(wǎng)，美國藥品網(wǎng)這兩個網(wǎng)站的網(wǎng)址分別是：/ 和 ,屬于 大型的藥品說明書及醫(yī)藥，衛(wèi)生，保健知識介紹網(wǎng)站.內(nèi)含大量有關(guān)藥品的信息中國藥網(wǎng)的藥品說明書：其網(wǎng)址為：/html/database/drugmanual/!該網(wǎng)站收集了 很多藥品說明書，其藥品說明書的網(wǎng)站首頁有藥品的分類和藥品檢索

17、功能，使用起來很方 便.此外該網(wǎng)站還有其他有用資料如：市場信息.藥品新聞和政府法規(guī)等中國國家食品藥品監(jiān)督管理局其網(wǎng)頁為：/WS01/CL0001/。這是中國國家食品藥品監(jiān)督管理 局的數(shù)據(jù)庫入門網(wǎng)頁.主要包含如下內(nèi)容：*OTC化學(xué)藥品說明書范本*OTC中藥說明書范本*執(zhí)業(yè)藥師認(rèn)定名單*藥包材生產(chǎn)企業(yè)數(shù)據(jù)庫*全國撤銷的藥品廣告*申請人申報受理情況*批準(zhǔn)的藥包材數(shù)據(jù)庫*上升為國家標(biāo)準(zhǔn)的藥品名單*批準(zhǔn)臨床研究的新藥*藥品注冊受理信息*藥品注冊批準(zhǔn)信息*可發(fā)布處方藥廣告的醫(yī)學(xué)藥學(xué)專業(yè)刊物名單*藥品注冊批件發(fā)送信息*國家基本藥物（2004年）*預(yù)防類生物制品說明書*醫(yī)療器械檢測中心受檢目錄*藥物臨床試驗(yàn)機(jī)構(gòu)名單*醫(yī)療器械分類目錄 醫(yī)療器械標(biāo)準(zhǔn)目錄*臨床前研究單位備案名單*全國撤銷保健品廣告維基百科全書：其網(wǎng)址為：維基百科